Breaking News Instant updates and real-time market news.

ADBE

Adobe

$497.75 /

+11.83 (+2.43%)

15:04
09/15/20
09/15
15:04
09/15/20
15:04

Adobe options imply 9.5% move in share price post-earnings

Pre-earnings options volume in Adobe is 1.9x normal with calls leading puts 10:7. Implied volatility suggests the market is anticipating a move near 9.5%, or $47.30, after results are released. Median move over the past eight quarters is 4.4%.

  • 15

    Sep

ADBE Adobe
$497.75 /

+11.83 (+2.43%)

09/14/20 Morgan Stanley
Adobe price target raised to $560 from $450 at Morgan Stanley
09/14/20 BMO Capital
Adobe price target raised to $535 from $440 at BMO Capital
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 Cowen
Adobe upgraded to Outperform from Market Perform at Cowen

TODAY'S FREE FLY STORIES

Hot Stocks
Honeywell sees returning to growth and margin expansion in 2021  07:18
10/30/20
10/30
07:18
10/30/20
07:18
HON

Honeywell

$164.57 /

+3.38 (+2.10%)

 
ShowHide Related Items >><<
HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

10/15/20 JPMorgan
Zebra Technologies price target raised to $296 from $280 at JPMorgan
10/13/20 Deutsche Bank
Honeywell price target raised to $169 from $153 at Deutsche Bank
10/07/20 JPMorgan
Honeywell price target raised to $198 from $185 at JPMorgan
08/11/20 RBC Capital
Honeywell downgraded to Sector Perform from Outperform at RBC Capital
HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

Hot Stocks
Honeywell sees sequential improvement across all segments in Q4 » 07:17
10/30/20
10/30
07:17
10/30/20
07:17
HON

Honeywell

$164.57 /

+3.38 (+2.10%)

Sees continued double…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

10/15/20 JPMorgan
Zebra Technologies price target raised to $296 from $280 at JPMorgan
10/13/20 Deutsche Bank
Honeywell price target raised to $169 from $153 at Deutsche Bank
10/07/20 JPMorgan
Honeywell price target raised to $198 from $185 at JPMorgan
08/11/20 RBC Capital
Honeywell downgraded to Sector Perform from Outperform at RBC Capital
HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

HON Honeywell
$164.57 /

+3.38 (+2.10%)

Earnings
Newell Brands sees FY20 normalized EPS $1.63-$1.69, consensus $1.27 » 07:17
10/30/20
10/30
07:17
10/30/20
07:17
NWL

Newell Brands

$16.81 /

+0.13 (+0.78%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

09/17/20 Deutsche Bank
Newell Brands price target raised to $18 from $17 at Deutsche Bank
07/16/20 JPMorgan
Newell Brands price target raised to $17 from $13 at JPMorgan
05/04/20 Deutsche Bank
Newell Brands price target lowered to $13 from $16 at Deutsche Bank
03/23/20 Citi
Newell Brands price target lowered to $15 from $24 at Citi
NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

Hot Stocks
AstraZeneca to sell rights to Atacand to Cheplapharm in more than 70 countries » 07:15
10/30/20
10/30
07:15
10/30/20
07:15
AZN

AstraZeneca

$51.06 /

+0.08 (+0.16%)

AstraZeneca has agreed to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$51.06 /

+0.08 (+0.16%)

AZN AstraZeneca
$51.06 /

+0.08 (+0.16%)

10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
AZN AstraZeneca
$51.06 /

+0.08 (+0.16%)

AZN AstraZeneca
$51.06 /

+0.08 (+0.16%)

AZN AstraZeneca
$51.06 /

+0.08 (+0.16%)

AZN AstraZeneca
$51.06 /

+0.08 (+0.16%)

Hot Stocks
KKR reports AUM $233.8B as of September 30 » 07:15
10/30/20
10/30
07:15
10/30/20
07:15
KKR

KKR

$34.78 /

+0.015 (+0.04%)

Compared to $221.8B as of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

08/05/20 Citi
Citi adds KKR to U.S. Focus List, ups price target to $47.50
07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler
KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

Earnings
Newell Brands sees Q4 normalized EPS 40c-46c, consensus 45c » 07:15
10/30/20
10/30
07:15
10/30/20
07:15
NWL

Newell Brands

$16.81 /

+0.13 (+0.78%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

09/17/20 Deutsche Bank
Newell Brands price target raised to $18 from $17 at Deutsche Bank
07/16/20 JPMorgan
Newell Brands price target raised to $17 from $13 at JPMorgan
05/04/20 Deutsche Bank
Newell Brands price target lowered to $13 from $16 at Deutsche Bank
03/23/20 Citi
Newell Brands price target lowered to $15 from $24 at Citi
NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

Hot Stocks
KKR reports book value per adjusted share was $20.26 as of September 30 » 07:15
10/30/20
10/30
07:15
10/30/20
07:15
KKR

KKR

$34.78 /

+0.015 (+0.04%)

Up 5%, compared with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

08/05/20 Citi
Citi adds KKR to U.S. Focus List, ups price target to $47.50
07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler
KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

Earnings
Newell Brands reports Q3 EPS 71c, consensus 43c » 07:14
10/30/20
10/30
07:14
10/30/20
07:14
NWL

Newell Brands

$16.81 /

+0.13 (+0.78%)

Reports Q3 revenue $2.7B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

09/17/20 Deutsche Bank
Newell Brands price target raised to $18 from $17 at Deutsche Bank
07/16/20 JPMorgan
Newell Brands price target raised to $17 from $13 at JPMorgan
05/04/20 Deutsche Bank
Newell Brands price target lowered to $13 from $16 at Deutsche Bank
03/23/20 Citi
Newell Brands price target lowered to $15 from $24 at Citi
NWL Newell Brands
$16.81 /

+0.13 (+0.78%)

Earnings
O2Micro sees Q4 revenue $22.7M-$24M, two est. $20.35M » 07:14
10/30/20
10/30
07:14
10/30/20
07:14
OIIM

O2Micro

$5.40 /

+0.17 (+3.25%)

O2Micro expects fourth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OIIM O2Micro
$5.40 /

+0.17 (+3.25%)

OIIM O2Micro
$5.40 /

+0.17 (+3.25%)

Recommendations
Amedisys price target raised to $280 from $246 at Credit Suisse » 07:13
10/30/20
10/30
07:13
10/30/20
07:13
AMED

Amedisys

$251.27 /

+0.47 (+0.19%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$251.27 /

+0.47 (+0.19%)

AMED Amedisys
$251.27 /

+0.47 (+0.19%)

09/21/20 Oppenheimer
Amedisys price target raised to $260 from $250 at Oppenheimer
09/10/20 Stephens
Amedisys price target raised to $245 from $235 at Stephens
09/02/20 BMO Capital
Amedisys price target raised to $270 from $250 at BMO Capital
07/30/20 Deutsche Bank
Amedisys price target raised to $260 from $220 at Deutsche Bank
AMED Amedisys
$251.27 /

+0.47 (+0.19%)

Earnings
Novo Nordisk reports operating profit up 7% at CER in first nine months of 2020 » 07:13
10/30/20
10/30
07:13
10/30/20
07:13
NVO

Novo Nordisk

$66.39 /

-0.1 (-0.15%)

Novo Nordisk reports that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$66.39 /

-0.1 (-0.15%)

NVO Novo Nordisk
$66.39 /

-0.1 (-0.15%)

10/15/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
10/12/20 Credit Suisse
Novo Nordisk Outperform rating affirmed at Credit Suisse
09/29/20 Berenberg
Novo Nordisk initiated with a Hold at Berenberg
08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
NVO Novo Nordisk
$66.39 /

-0.1 (-0.15%)

NVO Novo Nordisk
$66.39 /

-0.1 (-0.15%)

NVO Novo Nordisk
$66.39 /

-0.1 (-0.15%)

Earnings
O2Micro reports Q3 EPS 10c, one est. 9c » 07:12
10/30/20
10/30
07:12
10/30/20
07:12
OIIM

O2Micro

$5.40 /

+0.17 (+3.25%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OIIM O2Micro
$5.40 /

+0.17 (+3.25%)

OIIM O2Micro
$5.40 /

+0.17 (+3.25%)

Hot Stocks
Colgate-Palmolive reports Q3 adjusted gross profit margin 61.2%, up 220 bps  07:12
10/30/20
10/30
07:12
10/30/20
07:12
CL

Colgate-Palmolive

$76.71 /

-0.09 (-0.12%)

 
ShowHide Related Items >><<
CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

10/26/20 Truist
Colgate-Palmolive price target raised to $85 from $80 at Truist
07/22/20
Fly Intel: Top five analyst downgrades
07/22/20 Morgan Stanley
Colgate-Palmolive downgraded to Equal Weight on valuation at Morgan Stanley
07/22/20 Morgan Stanley
Colgate-Palmolive downgraded to Equal Weight from Overweight at Morgan Stanley
CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

Earnings
Phillips 66 reports Q3 adj. EPS (1c), consensus (79c) » 07:12
10/30/20
10/30
07:12
10/30/20
07:12
PSX

Phillips 66

$45.99 /

+1.84 (+4.17%)

Phillips 66 generated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

Recommendations
Alphabet price target raised to $1,950 from $1,850 at Credit Suisse » 07:12
10/30/20
10/30
07:12
10/30/20
07:12
GOOGL

Alphabet Class A

$1,555.19 /

+44.96 (+2.98%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

07:05 Today RBC Capital
Alphabet price target raised to $1,900 from $1,700 at RBC Capital
07:02 Today Morgan Stanley
Alphabet price target raised to $1,880 from $1,800 at Morgan Stanley
06:43 Today Mizuho
Alphabet price target raised to $1,810 from $1,750 at Mizuho
06:21 Today KeyBanc
Alphabet price target raised to $1,970 from $1,955 at KeyBanc
GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

GOOGL Alphabet Class A
$1,555.19 /

+44.96 (+2.98%)

Earnings
Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance » 07:11
10/30/20
10/30
07:11
10/30/20
07:11
ACB

Aurora Cannabis

$4.09 /

+0.26 (+6.79%)

Aurora Cannabis announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$4.09 /

+0.26 (+6.79%)

ACB Aurora Cannabis
$4.09 /

+0.26 (+6.79%)

10/28/20 Stifel
Aurora Cannabis price target lowered to C$3.60 from C$10.50 at Stifel
10/27/20 Cantor Fitzgerald
Aurora Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald
10/27/20 Cantor Fitzgerald
Aurora Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald
09/24/20 CIBC
Aurora Cannabis price target lowered to C$12 from C$20 at CIBC
ACB Aurora Cannabis
$4.09 /

+0.26 (+6.79%)

ACB Aurora Cannabis
$4.09 /

+0.26 (+6.79%)

ACB Aurora Cannabis
$4.09 /

+0.26 (+6.79%)

ACB Aurora Cannabis
$4.09 /

+0.26 (+6.79%)

Earnings
iRadimed not providing additional guidance at this time » 07:11
10/30/20
10/30
07:11
10/30/20
07:11
IRMD

iRadimed

$21.94 /

+0.03 (+0.14%)

The Company announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$21.94 /

+0.03 (+0.14%)

IRMD iRadimed
$21.94 /

+0.03 (+0.14%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
04/13/20 Roth Capital
iRadimed price target lowered to $30 from $32 at Roth Capital
IRMD iRadimed
$21.94 /

+0.03 (+0.14%)

Earnings
iRadimed reports Q3 adj. EPS 11c, two est. 10c » 07:10
10/30/20
10/30
07:10
10/30/20
07:10
IRMD

iRadimed

$21.94 /

+0.03 (+0.14%)

Reports Q3 revenue $7.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$21.94 /

+0.03 (+0.14%)

IRMD iRadimed
$21.94 /

+0.03 (+0.14%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
04/13/20 Roth Capital
iRadimed price target lowered to $30 from $32 at Roth Capital
IRMD iRadimed
$21.94 /

+0.03 (+0.14%)

Syndicate
Lufax 175M share IPO priced at $13.50 » 07:10
10/30/20
10/30
07:10
10/30/20
07:10
LU

Lufax

$0.00 /

+ (+0.00%)

The deal priced at the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 30
    Oct
Hot Stocks
Charter reports Q3 adjusted EBITDA $4.6B, up 13.6% y/y » 07:09
10/30/20
10/30
07:09
10/30/20
07:09
CHTR

Charter

$576.90 /

+4.32 (+0.75%)

Third quarter cable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHTR Charter
$576.90 /

+4.32 (+0.75%)

CHTR Charter
$576.90 /

+4.32 (+0.75%)

10/28/20 Benchmark
Charter price target raised to $725 from $640 at Benchmark
10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Charter price target raised to $735 from $700 at Citi
10/16/20 Barclays
Charter price target raised to $575 from $500 at Barclays
CHTR Charter
$576.90 /

+4.32 (+0.75%)

CHTR Charter
$576.90 /

+4.32 (+0.75%)

CHTR Charter
$576.90 /

+4.32 (+0.75%)

Hot Stocks
Paramount Gold files technical report on study for Grassy Mountain Gold Project » 07:08
10/30/20
10/30
07:08
10/30/20
07:08
PZG

Paramount Gold Nevada

$1.09 /

+0.03 (+2.83%)

Paramount Gold Nevada…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PZG Paramount Gold Nevada
$1.09 /

+0.03 (+2.83%)

PZG Paramount Gold Nevada
$1.09 /

+0.03 (+2.83%)

09/02/20 Alliance Global Partners
Paramount Gold Nevada transferred with Buy at Alliance Global Partners
07/01/20 Alliance Global Partners
Paramount Gold Nevada price target raised to $1.50 from $1.40 at Alliance Global
Downgrade
NuVasive downgraded to Neutral from Buy at BTIG » 07:08
10/30/20
10/30
07:08
10/30/20
07:08
NUVA

NuVasive

$49.27 /

+1.62 (+3.40%)

, GMED

Globus Medical

$52.55 /

+3.02 (+6.10%)

BTIG analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUVA NuVasive
$49.27 /

+1.62 (+3.40%)

NUVA NuVasive
$49.27 /

+1.62 (+3.40%)

06:37 Today Canaccord
NuVasive downgraded to Hold from Buy at Canaccord
05:29 Today Baird
NuVasive downgraded to Neutral from Outperform at Baird
10/19/20 Stifel
NuVasive initiated with a Buy at Stifel
07/20/20 Piper Sandler
NuVasive Q2 pre-announcement 'considerably' better than expected, says Piper
GMED Globus Medical
$52.55 /

+3.02 (+6.10%)

10/29/20 Credit Suisse
Globus Medical price target raised to $64 from $58 at Credit Suisse
10/19/20 Stifel
Globus Medical initiated with a Hold at Stifel
08/06/20 Northland
Globus Medical upgraded to Outperform after earnings at Northland
08/06/20 Northland
Globus Medical upgraded to Outperform from Market Perform at Northland
NUVA NuVasive
$49.27 /

+1.62 (+3.40%)

GMED Globus Medical
$52.55 /

+3.02 (+6.10%)

NUVA NuVasive
$49.27 /

+1.62 (+3.40%)

GMED Globus Medical
$52.55 /

+3.02 (+6.10%)

Downgrade
Ubisoft downgraded to Hold from Buy at Benchmark » 07:08
10/30/20
10/30
07:08
10/30/20
07:08
UBSFY

Ubisoft

$0.00 /

+ (+0.00%)

Benchmark analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

09/15/20 Citi
Citi opens '90-day Positive Catalyst Watch' on Ubisoft
09/11/20 JPMorgan
Ubisoft Overweight rating affirmed at JPMorgan after Forward event
09/11/20 Jefferies
Ubisoft upgraded to Buy from Hold at Jefferies
07/23/20 JPMorgan
Ubisoft price target raised to EUR 82 from EUR 79 at JPMorgan
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

Earnings
Altria Group narrows FY20 adj. EPS view to $4.30-$4.38 from $4.21-$4.38 » 07:08
10/30/20
10/30
07:08
10/30/20
07:08
MO

Altria Group

$36.88 /

+0.16 (+0.44%)

Consensus $4.32. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$36.88 /

+0.16 (+0.44%)

MO Altria Group
$36.88 /

+0.16 (+0.44%)

07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Barclays
Altria downgraded to Equal Weight on share losses at Barclays
07/08/20 Barclays
Altria Group downgraded to Equal Weight from Overweight at Barclays
07/07/20 Stifel
IQOS reduced exposure claim a 'win' for Philip Morris, Altria, says Stifel
MO Altria Group
$36.88 /

+0.16 (+0.44%)

MO Altria Group
$36.88 /

+0.16 (+0.44%)

MO Altria Group
$36.88 /

+0.16 (+0.44%)

MO Altria Group
$36.88 /

+0.16 (+0.44%)

Recommendations
Deckers Brands price target raised to $310 from $250 at Citi » 07:08
10/30/20
10/30
07:08
10/30/20
07:08
DECK

Deckers Brands

$257.74 /

+7.74 (+3.10%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DECK Deckers Brands
$257.74 /

+7.74 (+3.10%)

DECK Deckers Brands
$257.74 /

+7.74 (+3.10%)

10/22/20 BTIG
Deckers Brands price target raised to $291 from $253 at BTIG
10/22/20 Pivotal Research
Deckers Brands price target raised to $285 from $247 at Pivotal Research
10/21/20 Wedbush
Deckers Brands price target raised to $273 from $240 at Wedbush
10/12/20 Exane BNP Paribas
Deckers Brands upgraded to Outperform from Neutral at Exane BNP Paribas
DECK Deckers Brands
$257.74 /

+7.74 (+3.10%)

DECK Deckers Brands
$257.74 /

+7.74 (+3.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.